The Affera mapping and ablation system is the first on the market that can deliver both pulsed-field and radiofrequency ...

Growth of the market is driven by the prevalence of atrial fibrillation cases and cardiac disorders, a rise in the number of hypertension patients, growth in the geriatric population, and increasing ...

The following is a summary of “Impact of Ablation on AF burden and symptoms in HCM,” published in the October 2024 issue of ...

Woodland Heights Medical Center is pleased to announce treatment of its first patient with a new system that used Pulsed ...

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat Wall Street’s ...

Heart ablation involves burning defective heart tissue to improve electrical signaling. Learn who qualifies and more about ...

Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing ...